Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Wilson

Showing results (91-100 of 177) with videos related to

Pageof 18
Sort By:
Inflammatory Bowel Diseases|January 9, 2007
Genetics of the innate immune response in inflammatory bowel diseaseJohan Van Limbergen, Richard K Russell, Elaine R Nimmo, et al.
The American Journal of Gastroenterology|February 29, 2012
The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel diseasePaul Henderson, Aoife Casey, Sally J Lawrence, et al.
Inflammatory Bowel Diseases|January 31, 2015
Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapyPaul Henderson, Nicholas A Kennedy, Johan E Van Limbergen, et al.
Journal of the American Academy of Dermatology|June 20, 2006
A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitisDonald Belsito, David C Wilson, Erin Warshaw, et al.
Inflammatory Bowel Diseases|December 25, 2008
Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel diseaseMichael A Quail, Richard K Russell, Johan E Van Limbergen, et al.
Pediatrics|September 11, 2013
The rising incidence of celiac disease in ScotlandLois E White, Victoria M Merrick, Elaine Bannerman, et al.
Archives of Disease in Childhood|October 9, 2017
Biosimilar infliximab use in paediatric IBDLisa Richmond, Lee Curtis, Victoria Garrick, et al.
Biologics : Targets & Therapy|May 5, 2025
Adalimumab Biosimilars Demonstrate Long-Term Durability and Cost-Effectiveness in Paediatric Inflammatory Bowel Disease: A Real-World Two-Centre European Cohort StudySilvana Ancona, Katherine Armstrong, Chiara Longo, et al.
The Journal of Pediatrics|February 14, 2003
Glucose intolerance in children with cystic fibrosisMelinda P Solomon, David C Wilson, Mary Corey, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 19, 2006
6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experienceMadhur Ravikumara, Frank G H Hill, David C Wilson, et al.
Pageof 18

Showing results (91-100 of 177) with videos related to

Sort By:
Pageof 18
Inflammatory Bowel Diseases|January 9, 2007
Genetics of the innate immune response in inflammatory bowel diseaseJohan Van Limbergen, Richard K Russell, Elaine R Nimmo, et al.
The American Journal of Gastroenterology|February 29, 2012
The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel diseasePaul Henderson, Aoife Casey, Sally J Lawrence, et al.
Inflammatory Bowel Diseases|January 31, 2015
Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapyPaul Henderson, Nicholas A Kennedy, Johan E Van Limbergen, et al.
Journal of the American Academy of Dermatology|June 20, 2006
A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitisDonald Belsito, David C Wilson, Erin Warshaw, et al.
Inflammatory Bowel Diseases|December 25, 2008
Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel diseaseMichael A Quail, Richard K Russell, Johan E Van Limbergen, et al.
Pediatrics|September 11, 2013
The rising incidence of celiac disease in ScotlandLois E White, Victoria M Merrick, Elaine Bannerman, et al.
Archives of Disease in Childhood|October 9, 2017
Biosimilar infliximab use in paediatric IBDLisa Richmond, Lee Curtis, Victoria Garrick, et al.
Biologics : Targets & Therapy|May 5, 2025
Adalimumab Biosimilars Demonstrate Long-Term Durability and Cost-Effectiveness in Paediatric Inflammatory Bowel Disease: A Real-World Two-Centre European Cohort StudySilvana Ancona, Katherine Armstrong, Chiara Longo, et al.
The Journal of Pediatrics|February 14, 2003
Glucose intolerance in children with cystic fibrosisMelinda P Solomon, David C Wilson, Mary Corey, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 19, 2006
6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experienceMadhur Ravikumara, Frank G H Hill, David C Wilson, et al.
Pageof 18